Key result
High-dose citalopram and escitalopram were associated with increased out-of-hospital cardiac arrest risk compared to sertraline.
Why the study?
Conflicting results have been reported regarding the association between antidepressant use and out-of-hospital cardiac arrest risk.
Does the use of specific antidepressants increase the risk of out-of-hospital cardiac arrest compared to reference antidepressants?
Case-Control (n=10,987)
Yes
Does the use of specific antidepressants increase the risk of out-of-hospital cardiac arrest compared to reference antidepressants?
Answers are grounded in this paper and cite their sources.
High-dose citalopram, escitalopram, and mirtazapine are associated with an increased risk of out-of-hospital cardiac arrest, highlighting the need for careful dose titration.
Conflicting results have been reported regarding the association between antidepressant use and out-of-hospital cardiac arrest (OHCA) risk. We investigated whether the use of antidepressants is associated with OHCA. METHODS: We conducted a nationwide nested case-control study to assess the association of individual antidepressant drugs within drug classes with the hazard of OHCA. Cases were defined as OHCA from presumed cardiac causes. Cox regression with time-dependent exposure and time-dependent covariates was conducted to calculate hazard ratios (HR) and 95% confidence intervals (95% CIs) overall and in subgroups defined by established cardiac disease and cardiovascular risk factors. Also, we studied antidepressants with and without sodium channel blocking or potassium channel blocking properties separately. RESULTS: During the study period from 2001 to 2015 we observed 10 987 OHCA cases, and found increased OHCA rate for high-dose citalopram (>20 mg) and high-dose escitalopram (>10 mg; HR:1.46 [95% CI:1.27-1.69], HR:1.43 [95% CI:1.16-1.75], respectively) among selective serotonin reuptake inhibitors (reference drug sertraline), and for high-dose mirtazapine (>30; HR:1.59 [95% CI:1.18-2.14]) among the serotonin-norepinephrine reuptake inhibitors or noradrenergic and specific serotonergic antidepressants (reference drug duloxetine). Among tricyclic antidepressants (reference drug amitriptyline), no drug was associated with significantly increased OHCA rate. Increased OHCA rate was found for antidepressants with known potassium channel blocking properties (HR:1.14 [95% CI:1.05-1.23]), but for not those with sodium channel blocking properties. Citalopram, although not statistically significant, and mirtazapine were associated with increased OHCA rate in patients without cardiac disease and cardiovascular risk factors. CONCLUSION: Our findings indicate that careful titration of citalopram, escitalopram and mirtazapine dose may have to be considered due to drug safety issues.
No takes yet. Share an insight, caveat, or question.
Eroglu et al. (2022) conducted a case-control in Out-of-hospital cardiac arrest (n=10,987). Antidepressant drugs vs. Sertraline, duloxetine, and amitriptyline was evaluated on Out-of-hospital cardiac arrest (HR 1.46, 95% CI 1.27-1.69). High-dose citalopram and escitalopram were associated with increased out-of-hospital cardiac arrest risk compared to sertraline.
Synapse has enriched 10 related papers. Consider them for comparative context: